Human trials to begin Sept 2020 By Sola Ogundipe Johnson & Johnson as part of the commitment to bringing an affordable vaccine to the public on a not-for-profit basis for emergency pandemic use has announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020,  and it […]